AUS
NZ
UK
CA
USA
IND
Highlights
Procter & Gamble is set to report its fiscal Q1 2025 results on October 18, with anticipated revenues of $22.1 billion and earnings of $1.92 per share.
The company is experiencing slight sales growth, particularly in its grooming segment, despite challenges in its Baby Care line.
PG stock has appreciated by 20% this year, aligning with the S&P 500, while maintaining less volatility compared to the broader market.
Procter & Gamble (NYSE:PG) is scheduled to announce its fiscal Q1 2025 results on October 18, with projections indicating revenues of approximately $22.1 billion and earnings of $1.92 per share. These figures are expected to surpass consensus estimates of $21.96 billion in revenue and $1.90 in earnings. The company's top line is anticipated to achieve low single-digit growth, while earnings may rise in the mid-single-digit range, primarily influenced by restructuring charges.
Sales growth is expected to be driven by modest volume gains across various segments, particularly within the grooming category, which has shown resilience in recent periods. Pricing gains in the grooming segment are likely to continue, while sales in the Baby Care category may face challenges due to declining market share.
Procter & Gamble is currently undergoing a market portfolio restructuring, which will affect its overall margin profile. The company has signaled that it will recognize a charge of $750 million related to accumulated currency translation losses in Q1. Despite this, core earnings per share are projected to grow faster than sales, supported by a reduction in outstanding shares. Procter & Gamble plans to allocate between $6 billion and $7 billion for share repurchases during fiscal 2025.
In the prior quarter, Procter & Gamble reported flat revenues year-over-year at $20.5 billion, with 1% gains in both pricing and volume offset by a 2% adverse impact from foreign exchange rates. Segment performance varied, with Grooming experiencing 7% organic sales growth, while categories like Baby, Feminine & Family Care saw a 1% decline.
Currently, PG stock has increased by 20% this year, closely mirroring the performance of the S&P 500. The stock has displayed less volatility than the broader market in recent years. Valuation estimates place PG stock at around $170 per share, based on a 24x P/E multiple aligned with its average over the past four years. This assessment highlights Procter & Gamble's stable positioning relative to its industry peers.
